Variant NM_000492.4:c.744-33GATT[8]
Name | NM_000492.4:c.744-33GATT[8] |
#Exon/intron | intron 6 |
Legacy Name | TTGA repeats |
Class | non disease-causing |
Not found | dbSNP no rs |
Not found | Not found |
No patient found in CFTR-NGS catalogue |
TOTAL NUMBER OF PATIENTS | 30 |
---|---|
CF | 5 |
CFTR-RD | 18
|
Pending (NBS) | 7 |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
Phenotype | Patient ID | Variant status | Additional variants |
---|---|---|---|
CBAVD | 4679 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 834 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 840 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 857 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 881 | heterozygote | VUS3- Undef varying clinical consequence- Undef |
CBAVD | 912 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 978 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 765 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 4837 | heterozygote | CFTR-RD-causing- Undef varying clinical consequence- Undef |
CBAVD | 434 | heterozygote | varying clinical consequence - Cis CF-causing - Trans |
CBAVD | 490 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 491 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 548 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 614 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 643 | heterozygote | CFTR-RD-causing- Undef varying clinical consequence- Undef |
CBAVD | 4592 | heterozygote | varying clinical consequence - Cis CFTR-RD-causing - Trans |
Bronchiectasis | 4726 | heterozygote | CFTR-RD-causing- Undef varying clinical consequence- Undef |
CF | 4390 | heterozygote | varying clinical consequence - Cis CF-causing - Trans |
CF | 263 | heterozygote | varying clinical consequence - Cis CF-causing - Trans |
CF | 277 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CF | 280 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CF | 381 | heterozygote | varying clinical consequence - Cis CF-causing - Trans |
Pending (NBS) | 799 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
Pending (NBS) | 1547 | heterozygote | varying clinical consequence - Cis CF-causing - Trans |
Pending (NBS) | 4654 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
Pending (NBS) | 5342 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
Pending (NBS) | 3676 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
Pending (NBS) | 794 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
Pending (NBS) | 590 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
Pancreatitis | 3259 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
CFTR variants are clustered into five groups: |
|